(Q42907035)

10 November 2017

title

High-density lipoprotein therapy: is there hope? (English)

1 reference

10 November 2017

1 reference

Kunal N Bhatt

1

1 reference

10 November 2017

Bryan J Wells

series ordinal

2

1 reference

10 November 2017

Laurence S Sperling

series ordinal

3

1 reference

10 November 2017

Jefferson T Baer

series ordinal

4

1 reference

10 November 2017

publication date

1 August 2010

1 reference

Current treatment options in cardiovascular medicine

10 November 2017

published in

1 reference

10 November 2017

volume

12

1 reference

10 November 2017

issue

4

1 reference

10 November 2017

page(s)

315-328

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-010-0081-x

10 November 2017

exact match

0 references

cites work

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

1 reference

https://api.crossref.org/works/10.1007%2FS11936-010-0081-X

Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-010-0081-X

Extended-release niacin or ezetimibe and carotid intima-media thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-010-0081-X

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-010-0081-X

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-010-0081-X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

12 December 2020

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

12 December 2020

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Safety and tolerability of dalcetrapib

1 reference

12 December 2020

High-density lipoprotein as a therapeutic target: a systematic review

1 reference

12 December 2020

Mechanism of action of niacin

1 reference

12 December 2020

Efficacy and safety of an extended-release niacin (Niaspan): a long-term study

1 reference

12 December 2020

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

1 reference

12 December 2020

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

1 reference

12 December 2020

Diets and cardiovascular disease: an evidence-based assessment

1 reference

12 December 2020

Update on strategies to increase HDL quantity and function

1 reference

12 December 2020

Effects of torcetrapib in patients at high risk for coronary events

1 reference

12 December 2020

Influence of nicotinic acid on serum cholesterol in man.

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosc

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages

1 reference

12 December 2020

Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study).

1 reference

12 December 2020

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Athero

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease

1 reference

12 December 2020

A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.

1 reference

12 December 2020

The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis

1 reference

12 December 2020

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity

1 reference

12 December 2020

Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

12 December 2020

Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors

1 reference

12 December 2020

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

12 December 2020

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

1 reference

12 December 2020

10.1007/S11936-010-0081-X

Identifiers

DOI

1 reference

Dimensions Publication ID

10 November 2017

1022587949

0 references

1 reference